ACARIX A/S - CVR: 32648223

2022, DKK

10.07.2023

Bruttoresultat

-23.389'

Primær drift

-28.130'

Årets resultat

-28.426'

Aktiver

19.148'

Kortfristede aktiver

9.029'

Egenkapital

-2.760'

Afkastningsgrad

-147 %

Soliditetsgrad

-14 %

Likviditetsgrad

41 %

Resultat

10.07.2023

Årsrapport	2022 10.07.2023	2021 21.06.2022	2020 14.06.2021	2019 08.07.2020	2018 09.06.2019	2017 07.06.2018	2016 22.06.2017	2015 10.05.2016
Nettoomsætning
Bruttoresultat	-23.389.237	-24.113.811	-16.198.276	-18.563.612	-14.548.634	-12.918.804	-8.654.082	-3.734.797
Resultat af primær drift	-28.129.865	-28.130.238	-21.716.567	-24.156.598	-19.258.699	-16.437.971	0	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0	0
Finansielle indtægter	219.025	19.482	18.145	8.022	158.211	19.852	0	32
Finansieringsomkostninger	-515.089	-38.452	-52.072	-27.280	-58.986	-44.928	-733.997	-18.077
Andre finansielle omkostninger	0	0	0	0	0	0	0	0
Resultat før skat	-28.425.929	-28.149.208	-21.750.494	-24.175.856	-19.159.474	-16.463.047	-17.782.457	-5.914.990
Resultat	-28.425.929	-28.149.208	-21.750.494	-24.175.856	-19.158.138	-15.711.056	-15.607.922	-4.449.555
Forslag til udbytte	0	0	0	0	0	0	0	0

Aktiver

10.07.2023

Årsrapport	2022 10.07.2023	2021 21.06.2022	2020 14.06.2021	2019 08.07.2020	2018 09.06.2019	2017 07.06.2018	2016 22.06.2017	2015 10.05.2016
Kortfristede varebeholdninger	2.914.236	2.618.326	2.547.207	2.184.697	1.907.774	1.470.350	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	1.200.382	812.828	557.225	1.292.914	1.536.102	2.286.625	4.344.088	4.152.847
Likvider	4.914.189	2.055.887	2.430.503	3.825.596	1.548.987	3.269.347	12.627.326	1.722.373
Kortfristede aktiver	9.028.807	5.487.041	5.534.935	7.303.207	4.992.863	7.026.322	16.971.414	5.875.220
Immaterielle aktiver og goodwill	9.931.454	11.753.502	13.575.549	15.397.596	17.219.643	19.041.690	17.943.704	58.150.766
Finansielle anlægsaktiver	98.850	98.850	98.850	98.850	93.860	91.975	60.464	43.859
Materielle aktiver	88.615	141.944	96.666	0	0	0	0	0
Langfristede aktiver	10.118.919	11.994.296	13.771.065	15.496.446	17.313.503	19.133.665	18.004.168	58.194.625
Aktiver	19.147.726	17.481.337	19.306.000	22.799.653	22.306.366	26.159.987	34.975.582	64.069.845

Aktiver

10.07.2023

Passiver

10.07.2023

Årsrapport	2022 10.07.2023	2021 21.06.2022	2020 14.06.2021	2019 08.07.2020	2018 09.06.2019	2017 07.06.2018	2016 22.06.2017	2015 10.05.2016
Forslag til udbytte	0	0	0	0	0	0	0	0
Egenkapital	-2.759.717	1.933.056	9.486.142	16.616.095	19.839.189	21.502.384	24.213.440	57.274.015
Hensatte forpligtelser	0	0	0	0	0	0	0	3.997.235
Langfristet gæld til banker	0	0	0	0	0	0	0	0
Anden langfristet gæld		0	0	0	0	0	0	0
Leverandører af varer og tjenesteydelser	2.689.746	670.789	736.441	881.722	1.107.608	1.540.092	2.665.391	1.881.997
Kortfristede forpligtelser	21.907.443	15.548.281	9.819.858	6.183.558	2.467.177	4.657.603	10.762.142	2.798.595
Gældsforpligtelser	21.907.443	15.548.281	9.819.858	6.183.558	2.467.177	4.657.603	10.762.142	2.798.595
Forpligtelser	21.907.443	15.548.281	9.819.858	6.183.558	2.467.177	4.657.603	10.762.142	2.798.595
Passiver	19.147.726	17.481.337	19.306.000	22.799.653	22.306.366	26.159.987	34.975.582	64.069.845

Passiver

10.07.2023

Nøgletal

10.07.2023

Årsrapport	2022 10.07.2023	2021 21.06.2022	2020 14.06.2021	2019 08.07.2020	2018 09.06.2019	2017 07.06.2018	2016 22.06.2017	2015 10.05.2016
Afkastningsgrad	-146,9 %	-160,9 %	-112,5 %	-106,0 %	-86,3 %	-62,8 %	Na.	Na.
Dækningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	1.030,0 %	-1.456,2 %	-229,3 %	-145,5 %	-96,6 %	-73,1 %	-64,5 %	-7,8 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	-5.461,2 %	-73.156,8 %	-41.704,9 %	-88.550,6 %	-32.649,6 %	-36.587,4 %	Na.	Na.
Soliditestgrad	-14,4 %	11,1 %	49,1 %	72,9 %	88,9 %	82,2 %	69,2 %	89,4 %
Likviditetsgrad	41,2 %	35,3 %	56,4 %	118,1 %	202,4 %	150,9 %	157,7 %	209,9 %

Resultat

10.07.2023

Gæld

10.07.2023

Årsrapport

10.07.2023

Nyeste:01.01.2022- 31.12.2022(offentliggjort: 10.07.2023)

Information om virksomhedens regnskabsklasse:The annual report of ACARIX A/S for 2022 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B.

Oplysning om pantsætninger og sikkerhedsstillelser:8. Collaterals and securities No securities or mortgages exist at the balance sheet date.

Beretning

10.07.2023

Dato for ledelsens godkendelse af årsrapporten:2023-06-30

Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of ACARIX A/S for the financial year 1 January 2022 - 31 December 2022. The Annual Report is presented in accordance with the Danish Financial Statements Act. In our opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 December 2022 and of the results of the Company's operations for the financial year 1 January 2022 - 31 December 2022. In our opinion, the Management's Review includes a true and fair account of the matters addressed in the review. We recommend that the Annual Report be adopted at the Annual General Meeting. Hellerup, 30 June 2023 Executive Board Christian Lindholm Adm. direktør Board of Directors Philip Axel Wilhelm Siberg Fredrik Franz Johan Wilhelm Buch Louise Marie Counotte Janssen Formand Medlem Medlem Ulf Lennart Rosen Medlem

Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Exceptional circumstances No exceptional circumstances have affected recognition or measurement.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of ACARIX A/S for the financial year 1 January 2022 - 31 December 2022.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Financial Statements of Acarix A/S for 2022 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B as well as selected rules applying to reporting class C. The Annual Report has been prepared under the same accounting policies as last year. The Company's principal activities The company´s main activity is to develop solutions for rapid AI-based coronary artery disease (CAD). The Acarix CADScor®System is CE marked and approved by FDA De Novo for patients experiencing chest pain with suspected CAD and is designed to reduce millions of unnecessary, invasive, costly diagnostic procedures. The CADScor®System calculates a patient specific CAD score non-invasively in less than 10 minutes with 96% confidence.